.jpg)
2 hours ago
3
Article content
PARIS, FRANCE, 27 January 2026 – Ipsen (Euronext: IPN; ADR: IPSEY) announced today that Pierrick Lefranc will be appointed as Executive Vice President (EVP) and member of the Executive Leadership Team (ELT), as of 1 April 2026. Pierrick will succeed Aidan Murphy, EVP Technical Operations and Member of the ELT, who after 30 years of excellent service at Ipsen, will retire in March 2026.
THIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLY
Subscribe now to read the latest news in your city and across Canada.
- Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman, and others.
- Daily content from Financial Times, the world's leading global business publication.
- Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.
- National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.
- Daily puzzles, including the New York Times Crossword.
SUBSCRIBE TO UNLOCK MORE ARTICLES
Subscribe now to read the latest news in your city and across Canada.
- Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman and others.
- Daily content from Financial Times, the world's leading global business publication.
- Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.
- National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.
- Daily puzzles, including the New York Times Crossword.
REGISTER / SIGN IN TO UNLOCK MORE ARTICLES
Create an account or sign in to continue with your reading experience.
- Access articles from across Canada with one account.
- Share your thoughts and join the conversation in the comments.
- Enjoy additional articles per month.
- Get email updates from your favourite authors.
THIS ARTICLE IS FREE TO READ REGISTER TO UNLOCK.
Create an account or sign in to continue with your reading experience.
- Access articles from across Canada with one account
- Share your thoughts and join the conversation in the comments
- Enjoy additional articles per month
- Get email updates from your favourite authors
Sign In or Create an Account
or
Article content
Article content
Pierrick brings over 30 years of experience in the pharmaceutical industry. Throughout his career, he has led manufacturing operations and large-scale industrial projects, consistently driving improvements in productivity, quality, and regulatory compliance. Since July 2019, Pierrick has served as Senior Vice President at Ipsen overseeing global manufacturing activities, engineering, and enterprise excellence. He joined the company in 2013 and was appointed as Head of the Signes site in France in 2016. Pierrick will be based in Paris and report directly to David Loew, CEO.
Article content
Article content
By signing up you consent to receive the above newsletter from Postmedia Network Inc.
Article content
“I am pleased to welcome Pierrick to the Executive Leadership Team, bringing with him decades of leadership and strategic transformation expertise gained both within Ipsen and across major pharmaceutical companies,” said David Loew. “I would also like to extend my sincere appreciation for Aidan’s commitment to Ipsen and wish him much success and happiness in his next chapter. Throughout his leadership roles, Aidan has built a first-class manufacturing team across the globe while driving transformation and excellence within Technical Operations, which has been recognized by several Shingo awards.”
Article content
Article content
“I’m thrilled to be joining the Executive Leadership Team and look forward to being an integral member of Ipsen’s ongoing transformation,” said Pierrick. “I would also like to thank Aidan for his leadership throughout the years and wish him all the best for his retirement.”
Article content
About Ipsen
Article content
We are a global biopharmaceutical company with a focus on bringing transformative medicines to patients in three therapeutic areas: Oncology, Rare Disease and Neuroscience. Our pipeline is fueled by internal and external innovation and supported by nearly 100 years of development experience and global hubs in the U.S., France and the U.K. Our teams in more than 40 countries and our partnerships around the world enable us to bring medicines to patients in more than 100 countries.
Article content
Ipsen is listed in Paris (Euronext: IPN) and in the U.S. through a Sponsored Level I American Depositary Receipt program (ADR: IPSEY). For more information, visit www.ipsen.com.
Article content
Ipsen Contacts
Article content
Investors
Henry Wheeler [email protected] +33 766471149
Khalid Deojee [email protected] +33 666019526
English (US)